Grifols OTC Stock Today

Grifols Sa is trading at 13.41 as of the 27th of September 2021; that is No Change since the beginning of the trading day. The stock's open price was 13.41. Equity ratings for Grifols Sa ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2021 and ending today, the 27th of September 2021. Click here to learn more.
Check how we calculate scores

Grifols Sa OTC Stock Profile

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 24000 people. more on Grifols Sa
Grifols Sa ADR is not yet fully synchronised with the market data
Latest headline from What do the Fundamentals Predict for Grifols SA - ADR ADR Class B Stock - InvestorsObserver
Legal NameGrifols Sa ADR
New SymbolGRFS
CEO of Laboratorios Grifols SAAlbert Roura  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Grifols Sa's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
Grifols Sa ADR [GIKLY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 18.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grifols Sa's market, we take the total number of its shares issued and multiply it by Grifols Sa's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Grifols Sa ADR classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.36 B outstanding shares. Grifols Sa ADR has accumulated about 387.06 M in cash with 1.18 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Grifols Sa Probability Of Bankruptcy

Grifols Stock Price Odds Analysis

What are Grifols Sa's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Grifols Sa jumping above the current price in 90 days from now is about 10.56%. The Grifols Sa ADR probability density function shows the probability of Grifols Sa otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Grifols Sa has a beta of 0.0504. This usually indicates as returns on the market go up, Grifols Sa average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Grifols Sa ADR will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Grifols Sa ADR is significantly underperforming DOW.
 Odds Down 13.41HorizonTargetOdds Up 13.41 
89.33%90 days
Based on a normal probability distribution, the odds of Grifols Sa to move above the current price in 90 days from now is about 10.56 (This Grifols Sa ADR probability density function shows the probability of Grifols OTC Stock to fall within a particular range of prices over 90 days) .

Grifols Sa ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Grifols Sa market risk premium is the additional return an investor will receive from holding Grifols Sa long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Grifols Sa. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Grifols Sa's alpha and beta are two of the key measurements used to evaluate Grifols Sa's performance over the market, the standard measures of volatility play an important role as well.

Grifols Stock Against Markets

Picking the right benchmark for Grifols Sa otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Grifols Sa otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Grifols Sa is critical whether you are bullish or bearish towards Grifols Sa ADR at a given time.

Delisting Warning - GIKLY

Grifols Sa ADR was delisted

  The entity Grifols Sa ADR with a symbol GIKLY was delisted from OTC Exchange. Please use Grifols SA ADR with a symbol GRFS from now on.

Grifols Sa Corporate Directors

Grifols Sa corporate directors refer to members of a Grifols Sa board of directors. The board of directors generally takes responsibility for the Grifols Sa's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Grifols Sa's board members must vote for the resolution. The Grifols Sa board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Antonio Pares - Director of Planning and ControlProfile
Jose Garcia - Director General De Laboratorios GrifolsProfile
Anna Lluch - Independent DirectorProfile
Jose Gras - Director, Representative of Thorthol Holdings BVProfile
Please check Risk vs Return Analysis. Note that the Grifols Sa ADR information on this page should be used as a complementary analysis to other Grifols Sa's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Grifols OTC Stock analysis

When running Grifols Sa ADR price analysis, check to measure Grifols Sa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols Sa is operating at the current time. Most of Grifols Sa's value examination focuses on studying past and present price action to predict the probability of Grifols Sa's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Grifols Sa's price. Additionally, you may evaluate how the addition of Grifols Sa to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
The market value of Grifols Sa ADR is measured differently than its book value, which is the value of Grifols that is recorded on the company's balance sheet. Investors also form their own opinion of Grifols Sa's value that differs from its market value or its book value, called intrinsic value, which is Grifols Sa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grifols Sa's market value can be influenced by many factors that don't directly affect Grifols Sa ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grifols Sa's value and its price as these two are different measures arrived at by different means. Investors typically determine Grifols Sa value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grifols Sa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.